comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 16:23:51 - browse：8

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Creating egg and sperm cells from stem cells raises ethical issues

hotspot

focus

WSS

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Plastic surgeons increase patient psychiatric screenings

Nurses recount patients attacks

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Creating egg and sperm cells from stem cells raises ethical issues

Leading voice in opioid treatment defends methadone clinic system

focus

comprehensive

focus

Medicare proposal to cover medical devices draws a mixed reaction

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

In age of alternative facts, a scholarly course on calling out crap

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Novavax promises a turnaround & Lilly roils the obesity market

Virtual Event: March of the Biosimilars

Cancer drug shortages should be causing more outrage

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Virginia high school admissions case could be legal follow

Positive childhood experiences can help future health

entertainment

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Was Amgen transparent enough on FDA's concern on cancer drug?

Baby aspirin cuts fat buildup in liver disease patients, in small study

Neuroscience’s long legacy of racism

Physician executives need more than on

Stop the failed accountable care organization experiment

hotspot

hotspot

focus

Wikipedia